Investigational Drug Information for Prexasertib
✉ Email this page to a colleague
What is the development status for investigational drug Prexasertib?
Prexasertib is an investigational drug.
There have been 19 clinical trials for Prexasertib.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 25th 2024.
The most common disease conditions in clinical trials are Neoplasms, Carcinoma, and Colorectal Neoplasms. The leading clinical trial sponsors are Eli Lilly and Company, Dana-Farber Cancer Institute, and National Cancer Institute (NCI).
There are ninety-one US patents protecting this investigational drug and one hundred and seventy-one international patents.
Summary for Prexasertib
| US Patents | 91 |
| International Patents | 171 |
| US Patent Applications | 275 |
| WIPO Patent Applications | 144 |
| Japanese Patent Applications | 15 |
| Clinical Trial Progress | Phase 2 (2024-09-25) |
| Vendors | 50 |
Recent Clinical Trials for Prexasertib
| Title | Sponsor | Phase |
|---|---|---|
| A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC | Acrivon Therapeutics | PHASE2 |
| A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC | H. Lee Moffitt Cancer Center and Research Institute | PHASE2 |
| A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma | GOG Foundation | Phase 1/Phase 2 |
Clinical Trial Summary for Prexasertib
Top disease conditions for Prexasertib
Top clinical trial sponsors for Prexasertib
US Patents for Prexasertib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Prexasertib | ⤷ Start Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Start Trial |
| Prexasertib | ⤷ Start Trial | 5-(5-(2-(3-aminopropdoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2- -carbonitfile (S)-lactate monohydrate | Eli Lilly and Company (Indianapolis, IN) | ⤷ Start Trial |
| Prexasertib | ⤷ Start Trial | Targeted therapeutics | MADRIGAL PHARMACEUTICALS, INC. (West Conshohocken, PA) | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Prexasertib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Prexasertib | Australia | AU2017261372 | 2036-05-05 | ⤷ Start Trial |
| Prexasertib | Canada | CA3023278 | 2036-05-05 | ⤷ Start Trial |
| Prexasertib | China | CN107847398 | 2036-05-05 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
